Xylem Inc. (XYL) Guidance & Earnings Results

On 2026-07-28 Xylem Inc. raised guidance: "FY26 revenue ~$9.2B (~2% reported, 2-3% organic vs prior 2-3% and 2-4%); FY26 adj. EBITDA margin 23.1-23.5% (90-130 bps expansion); FY26 adj. EPS $5.55-$5.70 (raised from $5.35-$5.60); FY26 free cash flow margin…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

XYLXylem Inc.Follow XYL — free

Specialty Industrial Machinery · Industrials

—

Price chart with a free account

Market cap: 25.4B
P/E TTM: 25.9
Dividend yield: 1.5%
52-week: —
Next earnings: 27 Oct, in 3 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
28 Jul 26	Raised	FY26 revenue ~$9.2B (~2% reported, 2-3% organic vs prior 2-3% and 2-4%); FY26 adj. EBITDA margin 23.1-23.5% (90-130 bps expansion); FY26 adj. EPS $5.55-$5.70 (raised from $5.35-$5.60); FY26 free cash flow margin 10.2-11.0% (unchanged) · full year
28 Apr 26	Raised	FY revenue guidance raised to ~$9.2-$9.3B (from 1-3% reported to 2-3%); adj. EPS unchanged $5.35-$5.60 · full year
10 Feb 26	Raised	2026 revenue guidance $9.1-9.2B (+2-4% organic), adj. EPS $5.35-5.60 · full year
28 Oct 25	Raised	Revenue guidance raised to ~$9.0B (5-6% reported vs prior 4-5%); adjusted EPS raised to $5.03-$5.08 from $4.70-$4.85 · full year
31 Jul 25	Raised	FY25 revenue raised to $8.9-9.0B (from prior ~$8.6-8.7B implied by 1-2% growth); FY25 adj. EPS raised to $4.70-4.85 (from $4.50-4.70); FY25 adj. EBITDA margin 21.3-21.8% (+70-120bps YoY); FY25 free cash flow margin ~9-10% (unchanged) · full year

Xylem Inc. — questions

What guidance did Xylem Inc. give?: On 2026-07-28: "FY26 revenue ~$9.2B (~2% reported, 2-3% organic vs prior 2-3% and 2-4%); FY26 adj. EBITDA margin 23.1-23.5% (90-130 bps expansion); FY26 adj. EPS $5.55-$5.70 (raised from $5.35-$5.60); FY26 free cash flow margin 10.2-11.0% (unchanged)"
When does Xylem Inc. report earnings?: Xylem Inc.'s next earnings report is expected on 2026-10-27.

Every figure on this page comes from Xylem Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.